Assessing the effect of Cumin and black seed on glycemic control

Assessing the effect of Cumin (Cuminum Cyminum L) and black seed (Nigella sativa) on glycemic control

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140804018677N16

Enrollment

Registered

2022-04-24

Start date

2022-04-21

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Type 2 diabetes mellitus with hyperglycemia

Interventions

Intervention 1: Intervention group: Consuming 1000 mg softgel containing 900 mg black seed and 100 mg cumin oil every 12 hours for 12 weeks. Intervention 2: Control group: Consuming 1000 mg softgel co

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Having Type II diabetes diagnosed by gastroenterologist >18 years old Willing to participate

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Patients on insulin therapy Having known kidney disease

Design outcomes

Primary

Measure	Time frame
Fasting serum glucose level. Timepoint: Baseline and at the end of the study. Method of measurement: Blood test.;Serum HbA1C level. Timepoint: Serum HbA1C level. Method of measurement: Blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoodeh Razghei Jahromi

Shahid Beheshti University of Medical Sciences

soodehrazeghi@gmail.com+98 21 2235 7483

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026